Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Published online before print October 2, 2003, 10.1148/radiol.2292020296
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2292020296v1
229/2/554    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maas, M.
Right arrow Articles by den Heeten, G. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maas, M.
Right arrow Articles by den Heeten, G. J.
(Radiology 2003;229:554-561.)
© RSNA, 2003

Musculoskeletal Imaging

Quantification of Bone Involvement in Gaucher Disease: MR Imaging Bone Marrow Burden Score as an Alternative to Dixon Quantitative Chemical Shift MR Imaging—Initial Experience1

Mario Maas, MD, PhD, Cornelis van Kuijk, MD, PhD, Jaap Stoker, MD, PhD, Carla E. M. Hollak, MD, PhD, Erik M. Akkerman, PhD, Johannes F. M. G. Aerts, PhD and Gerard J. den Heeten, MD, PhD

1 From the Departments of Radiology (M.M., C.v.K., J.S., E.M.A., G.J.d.H.), Hematology (C.E.M.H.), and Biochemistry (J.F.M.G.A.), Academic Medical Center, Meibergdreef 9, Suite G1–231, 1105 AZ Amsterdam, the Netherlands. Received April 17, 2002; revision requested July 8; final revision received March 13, 2003; accepted April 7. Address correspondence to M.M. (e-mail: m.maas@amc.uva.nl).

PURPOSE: To develop a semiquantitative magnetic resonance (MR) imaging bone marrow burden (BMB) score with inclusion of both axial and peripheral bone marrow in Gaucher disease as an alternative to MR imaging with the Dixon quantitative chemical shift imaging (QCSI) technique.

MATERIALS AND METHODS: Two experienced musculoskeletal radiologists with no experience in evaluating Gaucher disease blindly analyzed MR images of lumbar spines and femora. Interobserver and intraobserver variability were tested. In addition, the BMB score was determined as a parameter to evaluate bone marrow response to enzyme supplementation therapy. Finally, the BMB score was compared with fat fraction measurements obtained with Dixon QCSI. Differences between groups were analyzed by using the nonparametric Mann-Whitney test. A P value of less than .05 was considered to represent significance. Correlation was calculated by using two-tailed nonparametric rank correlation (Spearman {rho}).

RESULTS: In 30 patients (mean age, 39.3 years; age range, 12–71 years) the mean fat fraction was 0.20 (range, 0.08–0.40). The BMB score range was 3–13 points. A significant correlation was found between the two observers when using BMB ({rho} = 0.91, P < .001). The intraobserver variation showed a significant correlation ({rho} = 0.99, P < .001). There was a significant correlation between BMB and QCSI ({rho} = -0.78, P < .001). Although BMB was less sensitive than Dixon QCSI, it showed enough sensitivity to allow detection of bone marrow response to enzyme supplementation therapy.

CONCLUSION: BMB is a reproducible semiquantitative scoring system that is easy to use. It combines MR imaging of both axial and peripheral bone marrow and shows a significant correlation with QCSI.

© RSNA, 2003

Index terms: Bone marrow, diseases, 33.671, 45.671 • Bone marrow, MR, 33.1214, 45.1214 • Gaucher disease, 33.671, 45.671 • Magnetic resonance (MR), chemical shift




This article has been cited by other articles:


Home page
 haematolHome page
M. Di Rocco, F. Giona, F. Carubbi, S. Linari, F. Minichilli, R. O. Brady, G. Mariani, and M. D. Cappellini
A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease
Haematologica, August 1, 2008; 93(8): 1211 - 1218.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
R. F. DeMayo, A. H. Haims, M. C. McRae, R. Yang, and P. K. Mistry
Correlation of MRI-Based Bone Marrow Burden Score with Genotype and Spleen Status in Gaucher's Disease
Am. J. Roentgenol., July 1, 2008; 191(1): 115 - 123.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Roentgenol.Home page
P. L. Robertson, M. Maas, and J. Goldblatt
Semiquantitative Assessment of Skeletal Response to Enzyme Replacement Therapy for Gaucher's Disease Using the Bone Marrow Burden Score
Am. J. Roentgenol., June 1, 2007; 188(6): 1521 - 1528.
[Abstract] [Full Text] [PDF]

Home page
 haematolHome page
M. de Fost, J. M.F.G. Aerts, J. E.M. Groener, M. Maas, E. M. Akkerman, M. G. Wiersma, and C. E.M. Hollak
Low frequency maintenance therapy with imiglucerase in adult type I Gaucher disease: a prospective randomized controlled trial
Haematologica, February 1, 2007; 92(2): 215 - 221.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
M. de Fost, C. E. M. Hollak, J. E. M. Groener, J. M. F. G. Aerts, M. Maas, L. W. Poll, M. G. Wiersma, D. Haussinger, S. Brett, N. Brill, et al.
Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement and chitotriosidase levels: a 2-center retrospective analysis
Blood, August 1, 2006; 108(3): 830 - 835.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2003 by the Radiological Society of North America.